Marco Carbone (MD, PhD) is an Associate Professor of Hepatology at the University of Milano-Bicocca and Honorary Consultant Hepatologist at the Niguarda Liver Transplant Centre, Milan. His research focuses on disease mechanisms in autoimmune and cholestatic liver diseases. He leads a program integrating molecular, histological, and radiological data to generate insights that inform mechanistic understanding, guide healthcare decisions, and support the design of innovative clinical trials.
He developed the UK-PBC risk score and the UDCA response score to advance stratified medicine in PBC. In 2021, he received the Rising Star in Gastroenterology award from United European Gastroenterology (UEG). He founded and co-chairs the Italian Registry of PBC and PSC, serves on the steering committee of the Global PBC Study Group, and is Vice-Chair of the PBC Foundation Medical Advisory Board. He currently chairs the EASL–AASLD Consensus on surrogate endpoints and real-world evidence in PBC to support drug development.